We provide evidence that NMD inhibition stabilizes the p53β and γ isoforms and restores p53 activity in not only p53-mutant cancer cells but also in cancer cells expressing WT p53 but are p53 deficient because of overexpression of its negative regulator MDM2. Here, TP53 is linked to cancer.